Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Published:2018-12-05 Issue:23 Volume:131 Page:2808-2816
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Liu Jing,Zhao Xiao-Su,Liu Yan-Rong,Xu Lan-Ping,Zhang Xiao-Hui,Chen Huan,Chen Yu-Hong,Wang Feng-Rong,Han Wei,Sun Yu-Qian,Yan Chen-Hua,Tang Fei-Fei,Mo Xiao-Dong,Liu Kai-Yan,Fan Qiao-Zhen,Huang Xiao-Jun,Chang Ying-Jun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference33 articles.

1. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: Results of the AML02 multicentre trial;Rubnitz;Lancet Oncol,2010

2. Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia;Walter;J Clin Oncol,2011

3. Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission;Walter;Blood,2013

4. Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia;Chen;J Clin Oncol,2015

5. Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation;Walter;Leukemia,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study;Blood Cancer Journal;2024-01-17

2. MRD-directed and risk-adapted individualized stratified treatment of AML;Chinese Journal of Cancer Research;2023

3. Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia;Cancers;2022-01-19

4. Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia;Transplantation and Cellular Therapy;2021-11

5. Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective;Frontiers in Oncology;2021-10-28